With a facility capable of storing 30,000 pallets, Egis has created Hungary’s largest single-space manufacturer’s warehouse for finished pharmaceutical products in the HelloParks industrial park in Fót, said Csaba Poroszlai, CEO of the pharmaceutical company, at the handover. He emphasized that the development, in line with the company’s growing production volume, supports serving the domestic and international markets covering more than 100 countries.

He added that based on the number of boxes sold, the company ranks first in the pharmaceutical market in Hungary, which is why it is particularly important that production is supported by a modern, uniform and reliable finished product logistics background.

Miklós Bódai, the Deputy Secretary of State responsible for foreign trade and economic coordination at the Ministry of Economy and Energy, said that the government considers the pharmaceutical industry an important sector, which traditionally contributes to the functioning of the Hungarian economy as a strong export sector.

The higher added value created by combining the existing knowledge, development ability and production capacity at home is a significant contribution to the development of the Hungarian economy, he added.

Rudolf Nemes, CEO of HelloParks, said that their agreement with Egis clearly shows that modern, sustainable and high-tech industrial properties also provide an operational background of strategic importance for the players in the pharmaceutical industry.

According to Egis’ announcement, the facility created in the HelloParks industrial park in Fót has a floor area of ​​nearly 20,000 square meters, of which about 1,000 square meters is office space. Nearly 60 employees participate in its daily operation.

The design of the warehouse meets the modern requirements of the pharmaceutical industry and the requirements of the European authorities: ensures the regulated storage of finished products, tempering conditions of 2-8 degrees Celsius and 15-25 degrees Celsius, and also fulfills strict environmental protection and fire protection regulations.

Egis Gyógyszergyár Zrt. is one of the leading generic pharmaceutical companies in Hungary and Central and Eastern Europe, with a 113-year history. Its activities cover all key areas of the pharmaceutical value chain, from research and development to the production of active ingredients and finished products to sales. Worldwide, more than 44 million people are cured annually with Egis medicines, they wrote.

Egis employs 4,800 employees in 18 countries, of which 3,750 are in Hungary, the announcement stated.

The company is committed to the development of its operations in Hungary and thus spent HUF 179 billion on the modernization of its premises in the last ten years, and almost HUF 23 billion on research and development in the 2024/2025 business year, they said.

Egis is a member of the Servier Group (an international pharmaceutical company based in France and managed by a non-profit foundation).

According to public data, in the business year ending on September 30, 2025, the group’s net sales were almost HUF 312 billion, compared to HUF 270 billion a year earlier, and its profit after tax was close to HUF 47 billion, compared to HUF 34 billion in the previous year.

Trademagazin.hu